Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
3,530
datasets available to search
ShareScore release 0.9.0
Dataset results
3,530 results for “Non-small cell lung cancer”
A Study of Abemaciclib (LY2835219) in Participants With Breast Cancer, Non-small Cell Lung Cancer, or Melanoma That Has Spread to the Brain
ClinicalTrials.gov study NCT02308020. IPD Sharing: YES. Countries: 9. Publications: 1.
Efficacy and Safety of High-Dose Rate Brachytherapy with Immunotherapy and Chemotherapy As Second-Line Treatment for Advanced Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT06518018. IPD Sharing: UNDECIDED. Countries: 1. Publications: 16.
Pazopanib As Pre-Surgical Therapy In Treatment-Naive Subjects With Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT00367679. IPD Sharing: Not stated. Countries: 3. Publications: 2.
Stereotactic Body Radiation Therapy (SBRT) in Metastatic Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT01185639. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Nintedanib in Molecularly Selected Patients With Advanced Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT02299141. IPD Sharing: NO. Countries: 1. Publications: 1.
Neoadjuvant Anti PD-1 Immunotherapy in Resectable Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT03197467. IPD Sharing: NO. Countries: 1. Publications: 3.
A Study Evaluating Platinum-Pemetrexed-Atezolizumab (+/-Bevacizumab) for Patients With Stage IIIB/IV Non-squamous Non-small Cell Lung Cancer With EGFR Mutations, ALK Rearrangement or ROS1 Fusion Progr
ClinicalTrials.gov study NCT04042558. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study Using a Genomic Predictor of Platinum Resistance to Guide Therapy in Stage IIIB/IV Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT00509366. IPD Sharing: Not stated. Countries: 1. Publications: 2.
A Study of Atezolizumab in Combination With Bevacizumab in Patients With EGFR Mutation Positive Stage IIIB-IV Non-Squamous Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT04426825. IPD Sharing: YES. Countries: 1. Publications: 1.
Efficacy and Safety of Pembrolizumab (MK-3475) With Lenvatinib (E7080/MK-7902) vs. Docetaxel in Participants With Metastatic Non-Small Cell Lung Cancer (NSCLC) and Progressive Disease (PD) After Plati
ClinicalTrials.gov study NCT03976375. IPD Sharing: YES. Countries: 18. Publications: 3.
Datopotamab Deruxtecan (Dato-DXd) and Pembrolizumab With or Without Platinum Chemotherapy in 1L Non-Small Cell Lung Cancer (TROPION-Lung07)
ClinicalTrials.gov study NCT05555732. IPD Sharing: YES. Countries: 29. Publications: 1.
A Study Comparing Adjuvant Alectinib Versus Adjuvant Platinum-Based Chemotherapy in Patients With ALK Positive Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT03456076. IPD Sharing: YES. Countries: 27. Publications: 2.
A Study of Pembrolizumab Plus Epacadostat With Platinum-based Chemotherapy Versus Pembrolizumab Plus Platinum-based Chemotherapy Plus Placebo in Metastatic Non-Small Cell Lung Cancer (KEYNOTE-715-06/E
ClinicalTrials.gov study NCT03322566. IPD Sharing: NO. Countries: 14. Publications: 1.
ARCHER 1009 : A Study Of Dacomitinib (PF-00299804) Vs. Erlotinib In The Treatment Of Advanced Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT01360554. IPD Sharing: Not stated. Countries: 23. Publications: 2.
Drug-Drug Interaction Study of TAK-788 and Midazolam in Participants With Advanced Non-small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT04051827. IPD Sharing: NO. Countries: 3. Publications: 0.
A Neoadjuvant Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Versus Chemotherapy Alone in Early Stage Non-Small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT02998528. IPD Sharing: Not stated. Countries: 15. Publications: 6.
Phase II Study of Pembrolizumab After Curative Intent Treatment for Oligometastatic Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT02316002. IPD Sharing: Not stated. Countries: 1. Publications: 1.
M7824 With cCRT in Unresectable Stage III Non-small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT03840902. IPD Sharing: YES. Countries: 15. Publications: 1.
An Investigational Drug, PF-02341066 Is Being Studied Versus Standard Of Care In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The Anaplastic Lymphoma Kinase
ClinicalTrials.gov study NCT00932893. IPD Sharing: Not stated. Countries: 22. Publications: 8.
Study of Tecemotide (L-BLP25) in Participants With Stage III Unresectable Non-small Cell Lung Cancer (NSCLC) Following Primary Chemoradiotherapy
ClinicalTrials.gov study NCT00960115. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.